To study the effect of TILAKUSUMADILEPA in skin disease
- Conditions
- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere. Ayurveda Condition: VIPADIKA,
- Registration Number
- CTRI/2022/01/039662
- Lead Sponsor
- Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik
- Brief Summary
The diagnosed patients of Vipadika will be treated for group A with Tilakusumadilepa mentioned in Bhaishajya Ratnawali 125 gms for 30 days used twice a day as topical application.The comparative drug for group B with Vipadikahar lepa mentioned in Sahastrayog will be given 125 gms for 30 days used twice a day as topical application.Assessement criteria will be those patients with classical signs and symptoms of vipadika -panipadsphutan vedana, Kandu, Khara sparshata,strava.Patients with other skin diseases Like Ringworm, scabies,Eczema etc will be excluded from study.The patients will be selected from kayachikitsa opd no 13..
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 70
- Patients with classical signs and symptoms of vipadika.
- panipadsphutan, vedana Kandu Kharasparshata Strava Patients of Age group.
- 60 years of Age. Patients willing to participate in the study , who give written consent.
- Patients below 18 & above 60 years of age.
- Patients with other uncontrolled systemic disorders like DM/ HTN/Cardiac disorders/leprosy/Tuberculosis/Malignancy will be excluded.
- Patients with other skin diseases Like Ringworm, scabies, Eczema etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method REDUCTION IN SIGN AND SYMPTOMS OF VIPADIKA 30 days
- Secondary Outcome Measures
Name Time Method COST EFFECTIVE TREATMENT 30 DAYS
Trial Locations
- Locations (1)
OPD no 13 kayachikitsa Ayurved Seva Sangha;s Ayurved Mahavidyalaya Panchwati Nashik.
🇮🇳Nashik, MAHARASHTRA, India
OPD no 13 kayachikitsa Ayurved Seva Sangha;s Ayurved Mahavidyalaya Panchwati Nashik.🇮🇳Nashik, MAHARASHTRA, IndiaShamala Sammaiah ElkapelliPrincipal investigator8999145793shamlaelkapelli926@gmail.com